Randomized phase II study comparing topotecan/cisplatin administration for 5 days versus 3 days in the treatment of extensive stage small cell lung cancer (SCLC)

✍ Scribed by Seifart, U.; Jensen, K.; Ukena, J.; Mueller, C.; Schröder, M.; Fuhr, H.G.; Keppler, U.; Neubauer, A.; Staab, H.J.; Wolf, M.

• Book ID: 119319142
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 166 KB
• Volume: 48
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/j.lungcan.2004.12.003